TickerFacts.

Summit Therapeutics Inc. (SMMT): Net Income

Annual figures by period end, from SEC filings.

-$1.08B
Year ended 2025-12-31
-$856.09M
Trailing 12 months to 2026-06-30
$10.87M2019-01-31: $10.87M2020-12-31: -$52.70M2021-12-31: -$88.60M2022-12-31: -$78.78M2023-12-31: -$614.93M2024-12-31: -$221.31M2025-12-31: -$1.08B-$1.08B
2019-01-31 Net Income (USD) 2025-12-31
Period endedNet IncomeChange YoYSource filing
2025-12-31-$1.08Bn/m2026-02-23, From 2025-01-01
2024-12-31-$221.31Mn/m2026-02-23, From 2024-01-01
2023-12-31-$614.93Mn/m2026-02-23, From 2023-01-01
2022-12-31-$78.78Mn/m2025-02-24, From 2022-01-01
2021-12-31-$88.60Mn/m2023-03-09, From 2021-01-01
2020-12-31-$52.70Mn/a2022-12-21, From 2020-01-01
No annual figure between 2019-01-31 and 2020-12-31.
2019-01-31$10.87Mn/a2021-03-31, From 2018-02-01

Net Income at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedNet IncomeChange YoY
Summit Therapeutics Inc. (SMMT)2025-12-31-$1.08Bn/m
Aurinia Pharmaceuticals Inc. (AUPH)2025-12-31$287.20Mn/m
Kiniksa Pharmaceuticals International, plc (KNSA)2025-12-31$59.01Mn/m
Kura Oncology, Inc. (KURA)2025-12-31-$278.67Mn/m
Cryoport, Inc. (CYRX)2025-12-31$78.30Mn/m
Vera Therapeutics, Inc. (VERA)2025-12-31-$299.62Mn/m
NewAmsterdam Pharma Co N.V. (NAMS)2025-12-31-$203.82Mn/m
Maravai Lifesciences Holdings, Inc. (MRVI)2025-12-31-$130.77Mn/m
Schrodinger, Inc. (SDGR)2025-12-31-$103.27Mn/m

Compare SMMT, AUPH, KNSA, KURA side by side · Screen every company in Pharmaceutical Preparations ↗